Related references
Note: Only part of the references are listed.Efficacy and safety of etravirine in treatment-experienced, HIV-1 patients: pooled 48 week analysis of two randomized, controlled trials
Christine Katlama et al.
AIDS (2009)
Genital Tract, Cord Blood, and Amniotic Fluid Exposures of Seven Antiretroviral Drugs during and after Pregnancy in Human Immunodeficiency Virus Type 1-Infected Women
Rosa F. Yeh et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2009)
Vancomycin Therapeutic Guidelines: A Summary of Consensus Recommendations from the Infectious Diseases Society of America, the American Society of Health-System Pharmacists, and the Society of Infectious Diseases Pharmacists
Michael J. Rybak et al.
CLINICAL INFECTIOUS DISEASES (2009)
Relationship between Initial Vancomycin Concentration-Time Profile and Nephrotoxicity among Hospitalized Patients
Thomas P. Lodise et al.
CLINICAL INFECTIOUS DISEASES (2009)
Endemic linezolid-resistant Staphylococcus epidermidis in a critical care unit
M. Trevino et al.
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES (2009)
Effectiveness of low-dose daptomycin in the treatment of vancomycin-resistant enterococcal urinary tract infections
Larry Fisher et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
High caspofungin levels in alveolar cells of a lung transplant patient with suspected pulmonary aspergillosis
Olaf Burkhardt et al.
INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2009)
Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial
Jeffrey L. Lennox et al.
LANCET (2009)
Insights from the Society of Infectious Diseases Pharmacists on Antimicrobial Stewardship Guidelines from the Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America
Richard H. Drew et al.
PHARMACOTHERAPY (2009)
Role of folate antagonists in the treatment of methicillin-resistant Staphylococcus aureus infection
Richard A. Proctor
CLINICAL INFECTIOUS DISEASES (2008)
Maraviroc for previously treated patients with R5 HIV-1 infection
Roy M. Gulick et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Raltegravir with optimized background therapy for resistant HIV-1 infection
Roy T. Steigbigel et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Antiretroviral drug exposure in the female genital tract: implications for oral pre- and post-exposure prophylaxis
Julie B. Dumond et al.
AIDS (2007)
Infectious Diseases Society of America and the Society for Healthcare Epidemiology of America guidelines for developing an institutional program to enhance antimicrobial stewardship
Timothy H. Dellit et al.
CLINICAL INFECTIOUS DISEASES (2007)
Improving empirical antibiotic treatment using TREAT, a computerized decision support system: cluster randomized trial
Mical Paul et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2006)
Relationship of MIC and bactericidal activity to efficacy of vancomycin for treatment of methicillin-resistant Staphylococcus aureus bacteremia
G Sakoulas et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2004)
Pharmacodynamics of vancomycin and other antimicrobials in patients with Staphylococcus aureus lower respiratory tract infections
PA Moise-Broder et al.
CLINICAL PHARMACOKINETICS (2004)
Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS)
GG Zhanel et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2003)
Attributable mortality of nosocomial candidemia, revisited
O Gudlaugsson et al.
CLINICAL INFECTIOUS DISEASES (2003)
A European study on the relationship between antimicrobial use and antimicrobial resistance
SLAM Bronzwaer et al.
EMERGING INFECTIOUS DISEASES (2002)
Aspergillosis case - Fatality rate: Systematic review of the literature
SJ Lin et al.
CLINICAL INFECTIOUS DISEASES (2001)
Share Paper
